Estudo de braço único fase 2 | Seguimento de longo prazo da combinação entre antígeno de maturação de célula B e células T receptoras de antígeno quimérico CD19 no mieloma múltiplo.

Long-Term Follow-Up of Combination of B-Cell Maturation Antigen and CD19 Chimeric Antigen Receptor T Cells in Multiple Myeloma – Journal of Clinical Oncology (link para o resumo – $ para o texto completo)

Comentário: Durable Response Achieved With CAR-T Combination in Relapsed/Refractory Multiple Myeloma – Hematology Advisor

Comentário no Twitter

🙌 Combination of anti-BCMA and anti-CD19 CAR T cells induced durable response in patients with relapsed/refractory #MultipleMyeloma ➡️ https://t.co/TkPRcTKSxg #JCO #MMSM pic.twitter.com/0OZAJtTXF1

— Journal of Clinical Oncology (@JCO_ASCO) April 15, 2022